Long range regulation of human FXN gene expression

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Puspasari, Novita ^a,b   Rowley, Simone M ^a   Gordon, Lavinia ^a   Lockhart, Paul J ^a,b   Ioannou, Panos A ^a,b   Delatycki, Martin B ^a,b,c   Sarsero, Joseph P ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FRATAXIN; LUCIFERASE; OCTAMER TRANSCRIPTION FACTOR 1; DNA; IRON BINDING PROTEIN; SPACER DNA;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CODON; CONTROLLED STUDY; DNA SEQUENCE; EXON; FRIEDREICH ATAXIA; FXN GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LOCUS; GENETIC CONSERVATION; HUMAN; HUMAN CELL; MARKER GENE; REPORTER GENE; UPREGULATION; BASE PAIRING; BINDING SITE; BIOLOGY; GENE DELETION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROMOTER REGION;

BACTERIA (MICROORGANISMS);

BASE PAIRING; BASE SEQUENCE; BINDING SITES; CHROMOSOMES, ARTIFICIAL, BACTERIAL; COMPUTATIONAL BIOLOGY; CONSERVED SEQUENCE; DNA; DNA, INTERGENIC; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; IRON-BINDING PROTEINS; MOLECULAR SEQUENCE DATA; OCTAMER TRANSCRIPTION FACTOR-1; PROMOTER REGIONS, GENETIC; SEQUENCE DELETION;

EID: 79960097201     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022001     Document Type: Article

References (45)

1. Pandolfo M, (2006) Friedreich ataxia: Detection of GAA repeat expansions and frataxin point mutations. Methods Mol Med 126: 197-216.
2. Filla A, De Michele G, Barbieri F, Campanella G, (1992) Early onset hereditary ataxias of unknown etiology. Review of a personal series. Acta Neurol (Napoli) 14: 420-430.
3. Harding AE, Zilkha KJ, (1981) 'Pseudo-dominant' inheritance in Friedreich's ataxia. J Med Genet 18: 285-287.
4. Romeo G, Menozzi P, Ferlini A, Fadda S, Di Donato S, et al. (1983) Incidence of Friedreich ataxia in Italy estimated from consanguineous marriages. Am J Hum Genet 35: 523-529.
5. Ramazzotti A, Vanmansart V, Foury F, (2004) Mitochondrial functional interactions between frataxin and Isu1p, the iron-sulfur cluster scaffold protein, in Saccharomyces cerevisiae. FEBS Lett 557: 215-220.
6. Yoon T, Cowan JA, (2004) Frataxin-mediated iron delivery to ferrochelatase in the final step of heme biosynthesis. J Biol Chem 279: 25943-25946.
7. Greene E, Entezam A, Kumari D, Usdin K, (2005) Ancient repeated DNA elements and the regulation of the human frataxin promoter. Genomics 85: 221-230.
8. Greene E, Mahishi L, Entezam A, Kumari D, Usdin K, (2007) Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia. Nucleic Acids Res 35: 3383-3390.
9. Li K, Singh A, Crooks DR, Dai X, Cong Z, et al. (2010) Expression of human frataxin is regulated by transcription factors SRF and TFAP2. PLoS One 5: e12286.
10. Herman D, Jenssen K, Burnett R, Soragni E, Perlman SL, et al. (2006) Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat Chem Biol 2: 551-558.
11. Saveliev A, Everett C, Sharpe T, Webster Z, Festenstein R, (2003) DNA triplet repeats mediate heterochromatin-protein-1-sensitive variegated gene silencing. Nature 422: 909-913.
12. Al-Mahdawi S, Pinto RM, Ismail O, Varshney D, Lymperi S, et al. (2008) The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues. Hum Mol Genet 17: 735-746.
13. Castaldo I, Pinelli M, Monticelli A, Acquaviva F, Giacchetti M, et al. (2008) DNA methylation in intron 1 of the frataxin gene is related to GAA repeat length and age of onset in Friedreich ataxia patients. J Med Genet 45: 808-812.
14. Rai M, Soragni E, Jenssen K, Burnett R, Herman D, et al. (2008) HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model. PLoS ONE 3: e1958.
15. Xu XS, Hong X, Wang G, (2009) Induction of endogenous gamma-globin gene expression with decoy oligonucleotide targeting Oct-1 transcription factor consensus sequence. J Hematol Oncol 2: 15.
16. De Biase I, Chutake YK, Rindler PM, Bidichandani BI, (2009) Epigenetic Silencing in Friedreich Ataxia Is Associated with Depletion of CTCF (CCCTC-Binding Factor) and Antisense Transcription. PLoS One 4: e7914.
17. Gottesfeld JM, (2007) Small molecules affecting transcription in Friedreich ataxia. Pharmacol Ther 116: 236-248.
18. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, et al. (2002) The human genome browser at UCSC. Genome Res 12: 996-1006.
19. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, et al. (2011) The UCSC Genome Browser database: update 2011. Nucleic Acids Res 39: D876-882.
20. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, et al. (2005) Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 15: 1034-1050.
21. Blanchette M, Kent WJ, Riemer C, Elnitski L, Smit AF, et al. (2004) Aligning multiple genomic sequences with the threaded blockset aligner. Genome Res 14: 708-715.
22. Schwartz S, Kent WJ, Smit A, Zhang Z, Baertsch R, et al. (2003) Human-mouse alignments with BLASTZ. Genome Res 13: 103-107.
23. Chiaromonte F, Yap VB, Miller W, (2002) Scoring pairwise genomic sequence alignments. Pac Symp Biocomput pp. 115-126.
24. King DC, Taylor J, Elnitski L, Chiaromonte F, Miller W, et al. (2005) Evaluation of regulatory potential and conservation scores for detecting cis-regulatory modules in aligned mammalian genome sequences. Genome Res 15: 1051-1060.
25. Kolbe D, Taylor J, Elnitski L, Eswara P, Li J, et al. (2004) Regulatory potential scores from genome-wide three-way alignments of human, mouse, and rat. Genome Res 14: 700-707.
26. Taylor J, Tyekucheva S, King DC, Hardison RC, Miller W, et al. (2006) ESPERR: learning strong and weak signals in genomic sequence alignments to identify functional elements. Genome Res 16: 1596-1604.
27. Jegga AG, Chen J, Gowrisankar S, Deshmukh MA, Gudivada R, et al. (2007) GenomeTrafac: a whole genome resource for the detection of transcription factor binding site clusters associated with conventional and microRNA encoding genes conserved between mouse and human gene orthologs. Nucleic Acids Res 35: D116-121.
28. Sarsero JP, Li L, Wardan H, Sitte K, Williamson R, et al. (2003) Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia. J Gene Med 5: 72-81.
29. Sarsero JP, Li L, Holloway TP, Voullaire L, Gazeas S, et al. (2004) Human BAC-mediated rescue of the Friedreich ataxia knockout mutation in transgenic mice. Mamm Genome 15: 370-382.
30. Cheng CK, Yeung CM, Hoo RL, Chow BK, Leung PC, (2002) Oct-1 is involved in the transcriptional repression of the gonadotropin-releasing hormone receptor gene. Endocrinology 143: 4693-4701.
31. Dong B, Zhao FQ, (2007) Involvement of the ubiquitous Oct-1 transcription factor in hormonal induction of beta-casein gene expression. Biochem J 401: 57-64.
32. Leclerc GM, Boockfor FR, (2005) Identification of a novel OCT1 binding site that is necessary for the elaboration of pulses of rat GnRH promoter activity. Mol Cell Endocrinol 245: 86-92.
33. Matheos DD, Ruiz MT, Price GB, Zannis-Hadjopoulos M, (1998) Oct-1 enhances the in vitro replication of a mammalian autonomously replicating DNA sequence. J Cell Biochem 68: 309-327.
34. Wu GD, Lai EJ, Huang N, Wen X, (1997) Oct-1 and CCAAT/enhancer-binding protein (C/EBP) bind to overlapping elements within the interleukin-8 promoter. The role of Oct-1 as a transcriptional repressor. J Biol Chem 272: 2396-2403.
35. Oktay Y, Dioum E, Matsuzaki S, Ding K, Yan LJ, et al. (2007) Hypoxia-inducible factor 2alpha regulates expression of the mitochondrial aconitase chaperone protein frataxin. J Biol Chem 282: 11750-11756.
36. Wang VE, Schmidt T, Chen J, Sharp PA, Tantin D, (2004) Embryonic lethality, decreased erythropoiesis, and defective octamer-dependent promoter activation in Oct-1-deficient mice. Mol Cell Biol 24: 1022-1032.
37. Sturm RA, Das G, Herr W, (1988) The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. Genes Dev 2: 1582-1599.
38. Tantin D, Schild-Poulter C, Wang V, Hache RJ, Sharp PA, (2005) The octamer binding transcription factor Oct-1 is a stress sensor. Cancer Res 65: 10750-10758.
39. Lins K, Remenyi A, Tomilin A, Massa S, Wilmanns M, et al. (2003) OBF1 enhances transcriptional potential of Oct1. Embo J 22: 2188-2198.
40. Nakshatri H, Nakshatri P, Currie RA, (1995) Interaction of Oct-1 with TFIIB. Implications for a novel response elicited through the proximal octamer site of the lipoprotein lipase promoter. J Biol Chem 270: 19613-19623.
41. Usheva A, Shenk T, (1994) TATA-binding protein-independent initiation: YY1, TFIIB, and RNA polymerase II direct basal transcription on supercoiled template DNA. Cell 76: 1115-1121.
42. Gambari R, (2004) New trends in the development of transcription factor decoy (TFD) pharmacotherapy. Curr Drug Targets 5: 419-430.
43. Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, et al. (2001) A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73: 56-65.
44. Hobert O, (2002) PCR fusion-based approach to create reporter gene constructs for expression analysis in transgenic C. elegans. Biotechniques 32: 728-730.
45. Frengen E, Weichenhan D, Zhao B, Osoegawa K, van Geel M, et al. (1999) A modular, positive selection bacterial artificial chromosome vector with multiple cloning sites. Genomics 58: 250-253.